NCT00868309View on ClinicalTrials.gov

A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab,

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

February 28, 2007

Conditions
Snake BiteBlood Coagulation Disorders
Interventions
BIOLOGICAL

Anavip

Anavip, 10 vials Intravenous (IV) every 2 hours until initial control has been achieved; then 3 maintenance doses of 4 vials every 6 hrs

BIOLOGICAL

CroFab

CroFab, 5 vials Intravenous (IV) every 2 hours until initial control has been achieved; then 3 maintenance doses of 2 vials every 6 hrs

Trial Locations (1)

85724

Tucson snakebite investigational site, Tucson

All Listed Sponsors
collaborator

University of Arizona

OTHER

lead

Instituto Bioclon S.A. de C.V.

INDUSTRY

NCT00868309 - A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab, | Biotech Hunter | Biotech Hunter